Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Januar 2025

Genmab — Januar 2025

Planlagt Fastgjort Låst Flyttet Genmab
702 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • L Offline
    L Offline
    lahn1
    wrote on sidst redigeret af
    #278

    Det er så med fare for at Gmab udvikler Erzo i RRMM og får oprette et off label salg i andre linjer, som gør at Gmab ikke vil sælge til aftalte pris.

    1 Reply Last reply
    0
    • S Offline
      S Offline
      Sukkeralf
      wrote on sidst redigeret af
      #279

      Uret starter når de sidste data er leveret - og ikke sikkert Janssen bruger 60 dage til at give svar uanset hvad, men omvendt hvorfor ikke bruge max tid.

      1 Reply Last reply
      0
      • SolsenS Offline
        SolsenS Offline
        Solsen
        wrote on sidst redigeret af
        #280

        Jeg så omtalt på yahoo, at JNJ risikerede dårligere kredit rating pga seneste M&A. Hvis de forhandler dybere kunne det jo være en fusion, hvor vi får nogle JNJ aktier. Mener de har en stor stak liggende fra deres fission for godt et år siden. Genmabs sælgerne står også og mangler stoffer 😉

        1 Reply Last reply
        0
        • SolsenS Offline
          SolsenS Offline
          Solsen
          wrote on sidst redigeret af
          #281

          Fusion ville også være mere passende, idet Genmabs stoffer fylder mere og mere hos JNJ !

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #282

            😄

            1 Reply Last reply
            0
            • S Offline
              S Offline
              Sukkeralf
              wrote on sidst redigeret af
              #283

              Genmab sælgeren vel i den situation blive fyret - JNJ har vel en af verdens største salgsorganisationer.

              1 Reply Last reply
              0
              • S Offline
                S Offline
                Sukkeralf
                wrote on sidst redigeret af
                #284

                sælgere

                1 Reply Last reply
                0
                • S Offline
                  S Offline
                  Sukkeralf
                  wrote on sidst redigeret af
                  #285

                  Uanset hvad bliver det stadig spændende at se data

                  1 Reply Last reply
                  0
                  • S Offline
                    S Offline
                    Sukkeralf
                    wrote on sidst redigeret af
                    #286

                    Ved nej kunne det jo stadig være Genmab har et bedre modtræk end HexaCD38 - who knows og de går efter at tage røven på JNJ. Det har de fortjent omend det nok er at håbe på for meget! Et HexElect stof af en art ville være stort

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #287

                      some more quotes from JPM interview- So I think the mix is actually quite ideal when you have both access to immuno-oncology molecules and different types of ADCs. You can actually come to combination regimens, which are completely chemo-free and potentially much better treatments for different types of cancer.

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #288

                        So what we intend to do is to actually explore them broadly. We have also other immuno-oncology antibodies right now. We have an HexaBody-OX40 in dose escalation with fantastic preclinical data you'll probably see going forward a mix of immune checkpoint targeted molecules together with and likely combinations also in clinical trials.

                        1 Reply Last reply
                        0
                        • L Offline
                          L Offline
                          lahn1
                          wrote on sidst redigeret af
                          #289

                          Hvordan skulle de tage røven på JnJ ?

                          1 Reply Last reply
                          0
                          • SolsenS Offline
                            SolsenS Offline
                            Solsen
                            wrote on sidst redigeret af
                            #290

                            Sikkert Sukkeralf. Men det er virkelig også et stort projekt Genmab har slået op med egen salgsstyrke !

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #291

                              this is the right approach going forward in order to progress therapy of cancer from very toxic types of therapy to much more benign therapies, which are giving you more long-lasting positive effects on the lives of cancer patients.

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #292

                                And that is, I think, the holy grail. I mean right now, we've made a lot of progress as an industry in the hematology field over the last years, and we have been I think, very active together with J&J in multiple myeloma, essentially turning that deadly in curable cancer and to cancer, you can actually live it for many, many years with very good quality of life. But the reality is that in solid tumors, this is actually much more difficult.

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #293

                                  And I think with these new approaches, and I think you need courageous innovative companies to actually take those approaches and test those approaches despite investors and analysts becoming restless at some point because it's not going quick enough for them I see a number of them in the room now smile. But I think we now have solid financials. We are very, very profitable. We intend to stay profitable, and we're going to bite and deep and actually hold on like a pit ball until we actually

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #294

                                    track thath.

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #295

                                      (Just to counter the argument that Genmab suddenly turned overnight into a company that now only buys late stage assets, as i just heard
                                      from someone... )

                                      1 Reply Last reply
                                      0
                                      • DarvinD Offline
                                        DarvinD Offline
                                        Darvin
                                        wrote on sidst redigeret af
                                        #296

                                        Lige præcis E L 🙂 pessimisterne har stået i kø den seneste tid. Men Genmab er stadig et powerhouse, og vi kan når som helst se nye spændende ting dukke op.
                                        JNJ har vel langt fra været overbeviste om, at de ikke vil opte in. Så var det sket. De har simpelthen ikke besluttet sig endnu, og det er et godt tegn. De har al mulig grund til - ikke at “drille” Genmab igen, efter de snød!!! dem mht royalty. Man kan ikke køre en fast strategi, om at drille sine partnere. Jo længere der går, jo højere er

                                        1 Reply Last reply
                                        0
                                        • DarvinD Offline
                                          DarvinD Offline
                                          Darvin
                                          wrote on sidst redigeret af
                                          #297

                                          For en deal

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper